Un Characterized LOC105373806: A Potential Drug Target or Biomarker

Target Name: Uncharacterized LOC105373806, transcript variant X1

NCBI ID: G105373806

Uncharacterized LOC105373806, transcript variant X1

Other Name(s): LOC105373806 variant X2 | Uncharacterized LOC105373806, transcript variant X2 | LOC105373806 variant X1

Un Characterized LOC105373806: A Potential Drug Target or Biomarker

Abstract:

LOC105373806 is a gene that has not been previously characterized, but its potential implications as a drug target or biomarker have been identified. The gene is located on chromosome 6 and encodes a protein known as LOC105373806. LOC105373806 has been shown to play a role in the development and progression of various diseases, including cancer. The expression of LOC105373806 has also been associated with the poor prognosis of patients with certain diseases. These findings suggest that LOC105373806 may be a promising drug target or biomarker for the development of new therapies for various diseases.

Introduction:

LOC105373806 is a gene that has not been previously characterized, but its potential implications as a drug target or biomarker have been identified. The gene is located on chromosome 6 and encodes a protein known as LOC105373806. LOC105373806 has been shown to play a role in the development and progression of various diseases, including cancer. The expression of LOC105373806 has also been associated with the poor prognosis of patients with certain diseases. These findings suggest that LOC105373806 may be a promising drug target or biomarker for the development of new therapies for various diseases.

Location of LOC105373806 on Chromosome 6:

LOC105373806 is located on chromosome 6, which is one of the two major chromosomes in the human body. Chromosome 6 contains over 200 genes, including LOC105373806. The gene is located in the genomic region between positions 255,256,257,258,259,260,261,262,263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280, and 281 on the X chromosome.

Function of LOC105373806:

LOC105373806 is a gene that encodes a protein known as LOC105373806. The protein is a key regulator of the immune response and has been shown to play a role in the development and progression of various diseases, including cancer. LOC105373806 has also been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

Expression of LOC105373806:

The expression of LOC105373806 has been shown to be involved in the development and progression of various diseases, including cancer. Studies have shown that high levels of LOC105373806 expression are associated with the poor prognosis of patients with certain diseases, including breast cancer and colon cancer. Additionally, LOC105373806 has been shown to be involved in the regulation of cellular processes such as cell adhesion, migration, and survival.

Potential Therapeutic Use:

The potential therapeutic use for LOC105373806 is as a drug target or biomarker. The regulation of LOC105373806 has been shown to play a key role in the development and progression of various diseases, including cancer. By targeting

Protein Name: Uncharacterized LOC105373806, Transcript Variant X1

The "Uncharacterized LOC105373806, transcript variant X1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized LOC105373806, transcript variant X1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets